End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
3.32
CNY
|
-0.60%
|
|
-2.35%
|
-21.33%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,983
|
2,754
|
3,860
|
4,811
|
4,540
|
3,458
|
Enterprise Value (EV)
1 |
5,343
|
4,523
|
6,264
|
6,282
|
5,539
|
4,423
|
P/E ratio
|
26
x
|
-3.69
x
|
10.8
x
|
45.4
x
|
-2.56
x
|
-7.54
x
|
Yield
|
1.79%
|
-
|
1.91%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.28
x
|
0.25
x
|
0.4
x
|
0.47
x
|
0.76
x
|
0.65
x
|
EV / Revenue
|
0.5
x
|
0.41
x
|
0.65
x
|
0.62
x
|
0.93
x
|
0.84
x
|
EV / EBITDA
|
6.76
x
|
17.1
x
|
5.4
x
|
6.62
x
|
-25.4
x
|
334
x
|
EV / FCF
|
-198
x
|
5.19
x
|
-40.8
x
|
6.33
x
|
6.62
x
|
47.4
x
|
FCF Yield
|
-0.5%
|
19.3%
|
-2.45%
|
15.8%
|
15.1%
|
2.11%
|
Price to Book
|
0.66
x
|
0.74
x
|
0.95
x
|
1.17
x
|
2.27
x
|
2.24
x
|
Nbr of stocks (in thousands)
|
819,514
|
819,514
|
819,514
|
819,514
|
819,514
|
819,514
|
Reference price
2 |
3.640
|
3.360
|
4.710
|
5.870
|
5.540
|
4.220
|
Announcement Date
|
3/20/19
|
4/9/20
|
3/18/21
|
3/29/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,791
|
11,020
|
9,572
|
10,132
|
5,941
|
5,282
|
EBITDA
1 |
789.7
|
264.9
|
1,159
|
949
|
-218
|
13.25
|
EBIT
1 |
229.6
|
-311.2
|
637.2
|
455.5
|
-664.1
|
-216.1
|
Operating Margin
|
2.13%
|
-2.82%
|
6.66%
|
4.5%
|
-11.18%
|
-4.09%
|
Earnings before Tax (EBT)
1 |
161.5
|
-695.6
|
544.7
|
210.7
|
-1,761
|
-441.2
|
Net income
1 |
117.9
|
-745.8
|
357.4
|
106
|
-1,773
|
-458.2
|
Net margin
|
1.09%
|
-6.77%
|
3.73%
|
1.05%
|
-29.84%
|
-8.68%
|
EPS
2 |
0.1400
|
-0.9100
|
0.4361
|
0.1294
|
-2.163
|
-0.5600
|
Free Cash Flow
1 |
-26.94
|
871.4
|
-153.6
|
992.1
|
836.3
|
93.27
|
FCF margin
|
-0.25%
|
7.91%
|
-1.6%
|
9.79%
|
14.08%
|
1.77%
|
FCF Conversion (EBITDA)
|
-
|
329%
|
-
|
104.55%
|
-
|
704.08%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
935.86%
|
-
|
-
|
Dividend per Share
2 |
0.0650
|
-
|
0.0900
|
-
|
-
|
-
|
Announcement Date
|
3/20/19
|
4/9/20
|
3/18/21
|
3/29/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,360
|
1,769
|
2,404
|
1,472
|
999
|
964
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.988
x
|
6.681
x
|
2.074
x
|
1.551
x
|
-4.58
x
|
72.79
x
|
Free Cash Flow
1 |
-26.9
|
871
|
-154
|
992
|
836
|
93.3
|
ROE (net income / shareholders' equity)
|
2.67%
|
-18.1%
|
9.18%
|
2.61%
|
-61.2%
|
-25.7%
|
ROA (Net income/ Total Assets)
|
1.51%
|
-2.16%
|
4.12%
|
2.77%
|
-5.01%
|
-2.09%
|
Assets
1 |
7,808
|
34,531
|
8,671
|
3,826
|
35,385
|
21,884
|
Book Value Per Share
2 |
5.510
|
4.530
|
4.970
|
5.020
|
2.440
|
1.890
|
Cash Flow per Share
2 |
1.390
|
2.270
|
2.070
|
2.370
|
2.230
|
1.710
|
Capex
1 |
122
|
183
|
90.3
|
263
|
102
|
124
|
Capex / Sales
|
1.13%
|
1.66%
|
0.94%
|
2.59%
|
1.72%
|
2.34%
|
Announcement Date
|
3/20/19
|
4/9/20
|
3/18/21
|
3/29/22
|
4/28/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -21.33% | 375M | | +5.14% | 103B | | -1.80% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|